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Cholinergic deficiency has been implicated in the pathogenesis of vascular cognitive
impairment (VCI), but the extent of involvement and underlying mechanism remain
unclear. In this study, targeting the early stage of VCI, we determined regional atrophy
within the basal forebrain and deficiency in cholinergic pathways in 25 patients with
vascular cognitive impairment no dementia (VCIND) compared to 24 healthy elderly
subjects. By applying stereotaxic cytoarchitectonic maps of the nucleus basalis of
Meynert (NbM), no significant atrophy was identified in VCIND. Using probabilistic
tractography analysis, our study tracked the two major white matter tracks which map
to cholinergic pathways. We identified significantly lower fractional anisotropy (FA) in
VCIND. Mediation analysis demonstrated that FA in the tracked pathways could fully
account for the executive dysfunction, and partly mediate the memory and global
cognition impairment. Our study suggests that the fibers mapped to the cholinergic
pathways, but not the NbM, are significantly impaired in VCIND. MRI-based in vivo
tracking of cholinergic pathways together with NbM measurement may become a
valuable in vivo marker for evaluating the cholinergic system in cognitive disorders.
Keywords: vascular cognitive impairment no dementia, cholinergic system, magnetic resonance imaging,
tractography, cognitive impairment
INTRODUCTION
The precise mechanisms underlying vascular cognitive impairment (VCI), the second common
cause of dementia (Kalaria et al., 2008), remain unclear. Several lines of evidence suggest a central
role for cholinergic deficiency. First, both cholinergic neuronal deficits (Keverne et al., 2007)
and cholinergic denervation (Mesulam et al., 2003) have been identified in patients with cerebral
autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL),
a purely genetic form of vascular dementia (VaD). Secondly, significantly decreased cerebrospinal
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fluid acetylcholine concentrations were observed in patients with
Binswanger or multi-infarct dementia (Tohgi et al., 1996; Wallin
et al., 2003). Finally, clinical trials have prompted potential
beneficial effects of cholinergic drugs in patients with VaD
(Erkinjuntti et al., 2002; Black et al., 2003; Wilkinson et al., 2003).
However, the exact nature of cholinergic involvement in
VCI is still unresolved. Postmortem studies in patients with
Binswanger type VaD (Tomimoto et al., 2005) and subcortical
VaD (Jung et al., 2012) have revealed relative preservation of
the nucleus basalis of Meynert (NbM) neurons with impaired
subinsular cholinergic fibers. An in vivo study showed NbM
atrophy in patients with subcortical ischemic VaD (Kim et al.,
2013). One possible explanation for this discrepancy may be
methodological limitations, e.g., the inability to obtain accurate
in vivo measurements of the NbM. The substantia innominata
(SI) thickness has been used to assess NbM atrophy (Hanyu
et al., 2007; Kim et al., 2013). Nevertheless, 2D measurements
of SI thickness have only provided a very rough estimate
of NbM volume (Teipel et al., 2005). Using the recently
developed stereotaxic cytoarchitectonic maps of the NbM based
on combined magnetic resonance imaging and histology of
postmortem brains, volume changes in NbM have been more
accurately measured (Teipel et al., 2005; Grothe et al., 2010).
Moreover, as Alzheimer’s disease (AD) research has already
addressed the importance of targeting early stages of the disease
process (Sperling et al., 2014), it is important to further evaluate
cholinergic involvement during early stages of VCI, i.e., vascular
cognitive impairment, no dementia (VCIND) as well.
In addition to the volume change in the NbM region, studies
have tried to investigate the white matter (WM) microstructure
of the cholinergic pathways (Behl et al., 2007; Kim et al., 2013).
The cholinergic input that innervate the cerebral cortex mostly
originate from the NbM Ch4 region (Mesulam and Geula,
1988), and their spatial distribution has been identified, following
medial and lateral cholinergic pathways that were observed in
a postmortem study (Selden et al., 1998). Previous studies have
visually rated WM hyperintensities within cholinergic pathways
using the cholinergic pathways hyperintensities scale (CHIPS)
(Behl et al., 2007; Kim et al., 2013). However, this approach did
not reflect the spatial damage of the whole cholinergic network
or reveal the underlying mechanism. Diffusion tensor imaging
(DTI) is an in vivo technology (Beaulieu, 2002) that is used
to investigate the WM microstructural integrity. Probabilistic
tractography can be applied to specifically investigate the WM
tracks that are mapping to the cholinergic pathways by tracking
fiber connections between regions of interest (ROIs) such as the
NbM and the cingulum. However, so far, only the medial pathway
was tracked in cognitively healthy participants (Hong and Jang,
2010), leaving it an open question whether the lateral pathway
can also be tracked.
Our study aimed to investigate the role of cholinergic
system changes in the pathogenesis of VCI. In pursuit of
this aim, we focused on patients with subcortical VCIND,
which is a relatively homogeneous condition and is supposed
to reflect early pathophysiological changes in VCI. Using
probabilistic tractography analysis, we tracked the fibers along
with the two major cholinergic pathways. In combination with
stereotaxic cytoarchitectonic maps of the NbM, we investigated
the contribution of the damage in the cholinergic system to
cognitive impairment in VCIND.
MATERIALS AND METHODS
Subjects
Twenty-five consecutive patients with subcortical VCIND
(47–69 years old) were prospectively recruited from the memory
clinic at Xuan Wu Hospital, Capital Medical University.
All patients were diagnosed by a consensus panel including
three senior neurologists and met the following inclusion
criteria: (1) Literate Han Chinese with a consistent caregiver
(>4 days/week); (2) complaint and/or informant report of
cognitive impairment involving memory and/or other cognitive
domains lasting for at least 3 months; (3) neither normal
nor demented according to the criteria of the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition (Winblad
et al., 2004), comprising the following criteria: a clinical dementia
rating (CDR) ≥0.5 on at least one domain (Hughes et al., 1982)
and global score = 0.5, and a Mini-Mental State Examination
(MMSE) score ≥ 20 (primary school) or ≥24 (junior school or
above) (Folstein et al., 1975; Zhang et al., 1990); and (4) normal
or slightly impaired daily living activities as defined by a total
score of ≤1.5 for the three functional CDR domains (home
and hobbies, community affairs, and personal care) (Zhang
et al., 1990). Participants were excluded who had any conditions
that would preclude completion of neuropsychological testing
or disorders other than subcortical VCIND that would affect
cognition.
All patients meeting the clinical criteria underwent brain
MRI including hippocampal assessment at screening. The MRI-
based entry criteria details were as follows: (1) multiple (≥3)
supratentorial subcortical small infarcts (3–20 mm in diameter)
with/without white matter lesions (WML) of any degree or
moderate to severe WML (score ≥ 2 according to the Fazekas
rating scale; Fazekas et al., 1987) with/without small infarct;
(2) absence of cortical or watershed infarcts, hemorrhages,
hydrocephalus, or WML with specific causes (e.g., multiple
sclerosis); and (3) no hippocampal or entorhinal cortex atrophy
(score 0 according to the medial temporal lobe atrophy scale of
Scheltens; Scheltens et al., 1992).
Twenty-four healthy elderly subjects, free from a history of any
major medical, neurological, or psychiatric illness, were recruited
from the community and served as a control group. No apparent
abnormal findings or cognitive impairments were expected to be
identified in MRI or neuropsychological testing.
This study received approval from the Xuan Wu Hospital
institutional review board and the methods were carried out in
accordance with the Declaration of Helsinki. Informed written
consent was obtained from each participant.
Neuropsychological Assessment
Neuropsychological evaluations included the MMSE, the
Montreal Cognitive Assessment (MoCA), the CDR scales, Digit
Span, the Trail Making Test (TMT) A and B, the WHO-UCLA
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Auditory Verbal Learning Test (AVLT), the Boston Naming
Test (BNT), the Hachinski Ischemic Scale (HIS), the Geriatric
Depression Scale (GDS), the Neuropsychiatric Inventory (NPI)
and the Activities of Daily Living (ADL) assessment.
Imaging Data Acquisition
Imaging data were collected on a 3 Tesla Siemens scanner.
T1 images with high spatial resolution, DTI images and Flair
images were collected. Brain structure data were collected with
a three-dimensional (3D) magnetization-prepared rapid gradient
echo (MP-RAGE) scan [repetition time (TR) = 1690 ms,
echo time (TE) = 2.56 ms, flip angle = 12◦, 1-mm isotropic
voxels covering the whole brain]. Diffusion data were collected
using a double spin-echo EPI sequence (TR = 8000 ms,
TE = 96 ms, flip angle = 90◦, FOV = 224 mm2, in-plane
resolution = 1.75 × 1.75 mm2 voxels, 54 contiguous 2-mm-
thick axial slices) with 64 non-collinear encoding directions
(b = 1000 s/mm2) and 11 images without diffusion weighting
(b = 0 s/mm2, b0). Flair images were acquired for Fazekas
rating (TR = 8000 ms, TE = 140 ms, time inverse = 2000 ms,
FOC = 224 mm, thickness = 6 mm, 1 mm gap, 20 slices). The
DTI images were collected with alignment to the AC-PC line, and
part of the cerebellum was missed for some subjects to include the
cerebral cortex.
Voxel-Based Morphometric Analysis
Analysis was conducted blind to diagnosis. To extract the NbM
volume, each participant’s T1 image was used to perform voxel-
based morphometric (VBM) analysis following the procedure
in FSL-VBM. The structural images were brain-extracted and
gray matter-segmented before being registered to the MNI
152 standard space using non-linear registration. The resulting
images were averaged and flipped along the x-axis to create
a left–right symmetric, study-specific gray matter template.
Second, all native gray matter images were non-linearly registered
to this study-specific template and “modulated” to correct
for local expansion (or contraction) due to the non-linear
component of the spatial transformation. The modulated gray
matter images were then smoothed with an isotropic Gaussian
kernel with a sigma of 3 mm. After preprocessing, the NbM
template, which was adopted from a previous study (Kilimann
et al., 2014), was registered to native T1 space to extract the gray
matter volume for each participant.
Probabilistic Tractography
The DTI data were analyzed using the FSL toolbox. In the
tractography analysis, the four ROIs which are illustrated in
the MNI space in Figure 1 were NbM, bilateral cingulum
(Cing), bilateral external capsule (ExCap), and bilateral claustrum
(Claus). The NbM template was adopted from a previous study
(Kilimann et al., 2014). The Cing and ExCap ROIs were selected
from the International Consortium of Brain Mapping-DTI WM
labels atlas. The Claus ROIs were defined in each participant’s
native TI space. Probabilistic tracking in native DTI space
was performed following procedures recommended by FSL
with a 2-ROI approach, as described in detail in our previous
work (Feng et al., 2016). Specifically, ROIs except for Claus
FIGURE 1 | Seeds for white matter tracking. Yellow for NbM, green for
bilateral cingulum (Cing), light blue for external capsule (ExCap) and red for
claustrum (Claus).
were coregistered to the participant’s native DTI space before
tractography analysis. For the Cing and ExCap ROIs, the
registration parameters of individual DTI image to standard
DTI image were inversely applied, to register the Cing and
ExCap from standard space to native space. As the NbM
ROI was originally in MNI space, the registration parameters
from standard diffusion space to standard T1 MNI space was
inversely applied to the NbM ROI, then was registered to native
diffusion space. DTI raw images were preprocessed, including
correction for motion and residual eddy current with the non-
brain tissues being removed. DTI fit was applied before the
algorithm implemented in FSL (BedpostX) was used to calculate
the diffusion parameters for each voxel. Probabilistic tracking was
then performed by repeating 5,000 random samples from the
NbM seed ROI voxels to the second ROI (Cing, Claus or ExCap)
voxels in a 2-ROI approach. These streamline samples started at
the first ROI voxels and propagated through the local probability
density functions of the estimated diffusion parameters. When a
2-ROI approach was used, only those streamlines initiated from
the first ROI that reached a voxel in the second ROI (or vice
versa) were retained. For each pathway, a waytotal-normalized
proportion map was used to generate a group mask with a
threshold at 80% of successful streamlines passing through a
given voxel at the group level in each VCIND and Control group.
The group mask was restricted to those voxels within the mean
fractional anisotropy (FA) skeleton to limit the effects of partial
voluming.
Diffusivity Indices Extraction
To better character the microstructure change in the cholinergic
pathway, diffusivity indices were extracted for analysis. FA is
an integrated measurement for WM microstructure. FA can
be decomposed into three mutually orthogonal eigenvectors
to reflect the diffusion coefficient along the direction of
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“apparent diffusion” (axial diffusivity, DA), and the diffusion
coefficients along two orthogonal directions embedded in the
plane perpendicular to the main diffusion direction. The
averaged of the two latter orthogonal eigenvectors is radial
diffusivity (DR). The sum of the three eigenvectors is mean
diffusivity (MD). Mode of anisotropy represents the shape of
the fiber. Larger mode of anisotropy (MO) was associated with
more linear shape. According to animal and human studies,
different diffusivity alteration patterns were associated with
varied mechanisms (Madden et al., 2012). To extract these
diffusivity indices, participants’ DTI datasets were normalized to
MNI152 (1 mm × 1 mm × 1 mm) space using FSL to enable
selection of spatially corresponding cholinergic pathway ROIs
across subjects (described below). Registration of FA images into
MNI space followed a series of procedures known as Tract-Based
Spatial Statistics (TBSS) (Smith et al., 2006). The raw images
were corrected for motion and residual eddy current with the
non-brain tissues being removed. The eddy current corrected
FA datasets were then affinely registered and resampled to the
1-mm isotropic MNI152 space. All MNI-transformed FA images
were then averaged to generate a mean FA image that was used
to create a common WM tract skeleton. This skeleton was then
thresholded at an FA value of 0.2 to minimize partial volume
effects after warping across subjects. Each participant’s aligned
FA image was subsequently projected onto the FA skeleton to
account for residual misalignments between participants after the
initial non-linear registration. Following the non-FA procedure
provided by FSL, MD, axial diffusivity (DA), radial diffusivity
(DR) and mode of anisotropy (MO) were also projected onto
the skeleton for each participant. Mean FA, MD, DA, DR and
MO values were then extracted from the skeletonized cholinergic
pathway masks for each participant.
Statistical Analysis
Demographics were compared between groups using
independent t-tests for age and education and Chi-square
tests for gender. As the CDR rating was 0.5 for each VCIND
participant and 0 for control participants, we used the CDR
sum of boxes for group comparisons in a one-way analysis of
variance with covariates (ANCOVA), controlling for age, gender
and education. A similar procedure was conducted for each
neuropsychological test.
After intracranial volume correction, the NbM volume was
compared between groups with one-way ANOVA and ANCOVA,
with and without controlling for age, gender and education. The
same ANCOVA procedure was applied for testing the group
difference in diffusivity indices.
To test whether brain structure contributed to
neuropsychological scores across groups, we performed a
partial correlation between neuropsychological scores, FA and
volume values, controlling for demographic difference, i.e., age,
sex, and education. CDR related correlation was performed in
the VCIND group only.
The mediation analyses sought to determine whether the
observed relationships between group and neuropsychological
scores could be better accounted for (i.e., mediated) by WM
microstructure (i.e., FA), following a widely used procedure
suggested by Salthouse (1993). To limit the statistical
comparisons, the FA, which integrates multiple diffusivity
components, was used in the mediation analysis. We followed
Baron and Kenny’s criterion for mediation analysis (Baron
and Kenny, 1986), which requires that all three variables
entered into a model be reliably correlated. To examine
whether WM microstructure mediated the relationship between
group and neuropsychological scores, we used hierarchical
regression analyses in which group was entered as a predictor
of neuropsychological scores both alone and after entering WM
microstructure into the model. Finally, we calculated the degree
to which each mediator attenuated the amount of variance
in neuropsychological scores that can be explained by group,
following a widely used procedure suggested by Salthouse (1993).
RESULTS
Demographics
Demographic findings are shown in Table 1. The patients and
controls showed significant differences in gender, but comparable
age and years of education. As indicated by the HIS and Fazekas
scores, the VCIND group exhibited significantly higher vascular
factors and WM lesions. The Control group outperformed the
VCIND group in each of the neuropsychological tests. For CDR
ratings, all of the VCIND patients were rated at 0.5 and all of
the controls were rated at 0. The CDR sum of boxes (CDR-SB)
showed variability across VCIND participants and was used for
subsequent analyses.
NbM Volume
For cholinergic basal forebrain analysis, using previously
developed stereotaxic cytoarchitectonic maps, the NbM volume
versus intracranial volume ratio was comparable between the
Control group (Mean ± SD, 0.0011 ± 0.00014) and the VCIND
group (0.0011 ± 0.00011). The group differences did not reach
statistical significance with or without controlling for age, gender
and education (Fs< 1).
Cholinergic Pathways
Figures 2A,B demonstrates the tracked medial and lateral WM
pathways in the probabilistic tractography analyses. The medial
pathway from the NbM went through the genu portion of
the corpus callosum and then targeted at the cingulum. For
the lateral pathway, the ExCap and Claus divisions were both
successfully tracked. The ExCap division projected to the inferior
frontal cortex via the anterior corona radiata. The ExCap division
also projected to the parietal and temporal cortex via the
posterior thalamic radiation and superior longitudinal fasciculus.
Additionally, the ExCap division targeted the splenium of
corpus callosum and merged with the occipital cortex along
with the inferior longitudinal fasciculus. In the Claus division,
the fibers projected to fibers along with the claustrum and
external capsule merged with the inferior fronto-occipital
fasciculus.
Frontiers in Aging Neuroscience | www.frontiersin.org 4 February 2017 | Volume 9 | Article 47
fnagi-09-00047 February 24, 2017 Time: 15:22 # 5
Liu et al. Cholinergic Involvement in VCIND
TABLE 1 | Characteristics of controls and patients.
Control VCIND t / x2/ F
Demographic characteristics
N 24 25
Age 59.4 (6.3) 60.8 (5.9) 0.8
Education 11.4 (2.8) 11.3 (2.9) 0.1
Gender (M/F) 4/20 14/11 8.2∗∗
Clinical characteristics
HIS 0.2 (0.4) 4.6 (3.7) 28.6∗∗∗
Fazekas 0 3.3 (1.1) 159.8∗∗∗
Neuropsychological scores
MMSE 29.0 (1.1) 27.1 (1.8) 16.3∗∗∗
MoCA 27.0 (1.8) 23.0 (3.2) 25.5∗∗∗
CDT 14.1 (0.8) 13.3 (1.3) 4.2∗
ADL 20.0 (0) 21.4 (3.2) 1.7
TMT-A 48 (20) 76 (40) 4.9∗
TMT-B 84 (55) 167 (99) 5.4∗
TMT-B-A 36 (49) 87 (75) 2.2
BNT 25.6 (3.2) 23.4 (3.9) 7.3∗∗
FDS 8.3 (0.8) 8.2 (1.2) 0.1
BDS 5.4 (1.5) 4.4 (1.1) 5.3∗
AVLT_Im 31.8 (5.6) 23.8 (6.3) 10.9∗∗∗
AVLT_De 12.0 (2.3) 7.8 (3.1) 18.3∗∗∗
AVLT_Clue 13.4 (1.7) 10.1 (2.8) 15.9∗∗∗
AVLT_Re 13.8 (1.4) 11.9 (2.6) 4.0∗
CDR-SB 0 1.4 (0.8) 48.1∗∗∗
GDS 3.2 (3.1) 4.6 (2.6) 1.4
NPI 0.6 (1.9) 1.4 (1.4) 1.5
For age and education, independent t-tests were performed. For gender and
genotype, a chi-square test was performed (df= 1). For all other variables, one-way
ANCOVA tests were performed by setting the group as an independent variable
and age, education and gender as covariates (df = 1,55). ∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001. M, male; F, female; HIS, Hachinski Ischemia Scale; Fazekas, Fazekas
scale; MMSE, Minimum Mental State Examination; MoCA, Montreal Cognitive
Assessment; CDT, clock drawing test; ADL, Activities of Daily Living scale; TMT, Trial
Making Test; TMT-B-A, the difference between TMT-B and TMT-A; BNT, Boston
Naming Test; FDS, forward digit span; BDS, backward digit span; AVLT, the WHO-
UCLA Auditory Verbal Learning Test (Im, immediate; De, delay; Re, recognition);
CDR-SB, Clinical Dementia Rating Scale Sum of Boxes; GDS, Geriatric Depression
Scale; NPI, Neuropsychiatric Inventory.
Diffusivity Indices Results
Significantly higher FA values were identified in the Control
group than the VCIND group for all three pathways [Figure 2C,
F(1,55) = 13.8, 19.6 and 21.6 for Cing, Claus and ExCap,
respectively, ps < 0.001]. After controlling for age, gender,
and education, the significant group differences prevailed in all
diffusivity indices except for DA and MO in the Cing pathway
(Table 2). Interestingly, the VCIND group exhibited higher DR
and MD values, but also higher DA values compared with the
controls.
Correlations between Cholinergic
Pathways and Neuropsychological
Scores
Partial correlation analyses controlling for age, gender, and
education were used to study the relationship between WM
FIGURE 2 | Tracked pathways and FA values. (A) 3D Reconstructed
pathways (blue) for each division and the ROIs. Yellow for NbM, green for
bilateral cingulum, light blue for external capsule and red for claustrum.
(B) Overlapped pathways. Yellow for NbM seed, green for the pathway
passing through the cingulum, light blue for the pathway passing through the
external capsule, and red for the pathway passing through the claustrum.
(C) Significantly higher FA values in the Control group compared with the
VCIND group in all three cholinergic pathways. Cing, cingulum; ExCap,
external capsule; Claus, claustrum. ∗∗∗p < 0.001.
pathways and neuropsychological scores. For general cognitive
assessment, we found a significant negative correlation between
CDR-SB and FA in the three pathways, showing that better FA
was associated with a lower dementia rating. We also found
significant positive correlations between FA in the three pathways
and MoCA and MMSE, revealing that a higher FA was associated
with better cognitive function. For specific cognitive domains,
a higher FA in the three pathways was associated with better
memory function as measured by AVLT, language function as
measured by BNT, processing speed as measured by TMT-A, and
executive function as measured by CDT and BDS (Table 3).
Mediation Results
To reduce potential statistical comparisons, only those variables
that were significantly correlated with FA in all three tracts were
included. Therefore, FA mediations on the associations between
diagnostic group and MoCA, MMSE, CDT, BDS and AVLT were
tested.
For MMSE, the group but not the FA effect was significant
when both FA and group were entered into the regression
model, revealing that FA did not mediate the group-MMSE
association. For MoCA and AVLT, both FA and group effects
were significant when both FA and group were entered into
the regression model (ps < 0.05), revealing that the FA partly
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TABLE 2 | Diffusive indices [mean value (SD)] in Control and VCIND
groups.
Control VCIND F(1,55)
DA
Cing 0.00129 (0.00003) 0.00132 (0.00006) 3.6
Claus 0.00127 (0.00003) 0.00132 (0.00006) 11.1∗∗
ExCap 0.00126 (0.00003) 0.00131 (0.00005) 10.0∗∗
DR
Cing 0.00058 (0.00003) 0.00064 (0.00005) 13.2∗∗∗
Claus 0.00058 (0.00003) 0.00066 (0.00006) 21.1∗∗∗
ExCap 0.00054 (0.00003) 0.00062 (0.00007) 18.9∗∗∗
MD
Cing 0.00082 (0.00002) 0.00087 (0.00006) 10.6∗∗∗
Claus 0.00081 (0.00002) 0.00088 (0.00006) 19.4∗∗∗
ExCap 0.00078 (0.00002) 0.00085 (0.00006) 16.9∗∗∗
MO
Cing 0.52 (0.03) 0.50 (0.04) 3.5
Claus 0.13 (0.01) 0.12 (0.01) 6.2∗
ExCap 0.55 (0.02) 0.52 (0.03) 7.3∗∗
∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
TABLE 3 | Partial correlations between FA and neuropsychological scores.
Cing Claus ExCap
CDR −0.46∗ −0.44∗ −0.64∗∗∗
MoCA 0.48∗∗∗ 0.49∗∗∗ 0.56∗∗∗
MMSE 0.34∗ 0.34∗ 0.38∗∗
CDT 0.30∗ 0.24∗ 0.38∗∗
TMT-A −0.24 −0.30∗ −0.38∗
TMT-B −0.27 −0.25 −0.34∗
BNT 0.21 0.26 0.33∗
BDS 0.37∗ 0.39∗∗ 0.32∗
AVLT_Im 0.36∗∗ 0.39∗∗ 0.46∗∗
AVLT_De 0.41∗∗ 0.46∗∗∗ 0.54∗∗∗
AVLT_Clue 0.31∗ 0.41∗∗ 0.44∗∗
AVLT_Re 0.34∗ 0.38∗∗ 0.43∗∗
∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
mediated the group-cognition relationship. For CDT and BDS,
significant group-cognition was absent when FA was entered
into the regression model, but the FA effects were significant or
tended to reach significance, revealing full mediation of FA on
the group-cognition association. Specifically, as shown in Table 4,
after controlling for FA in Cing, Claus and ExCap pathways,
group-related variance in CDT was attenuated by 83.77, 91.67,
and 99.17%, respectively, along with no significant group effect in
the full model. For BDS, as shown in Table 4, after controlling for
FA in Cing, Claus and ExCap pathways, group-related variance
in CDT was attenuated by 78.57, 85.71, and 78.57%, respectively.
DISCUSSION
In contrast to the consistent findings of NbM shrinking in
Alzheimer’s disease (Teipel et al., 2011; Grothe et al., 2012), it
TABLE 4 | Mediation models testing the effects of group and FA on the
Group-CDT and Group-BDS score relationship.
R2 R2
change
F Percentage
attenuation
Beta
FA mediation on Group-CDT
Model 1
Group 0.12 6.2∗∗∗ 0.347∗
Model 2
FA of Cing 0.16 8.43∗∗ 0.30#
Group 0.18 0.02 4.75∗ 83.33 0.17
FA of Claus 0.21 12.15∗∗∗ 0.41∗
Group 0.22 0.01 6.11∗∗∗ 91.67 0.09
FA of ExCap 0.23 13.16∗∗∗ 0.45∗
Group 0.23 0.001 6.48∗∗ 99.17 0.04
FA mediation on Group-BDS
Model 1
Group 0.14 7.35∗∗ 0.37∗∗
Model 2
FA of Cing 0.17 9.19∗∗ 0.29#
Group 0.20 0.03 5.58∗∗ 78.57 0.21
FA of Claus 0.18 10.35∗∗ 0.32∗
Group 0.20 0.02 9.69∗∗ 85.71 0.18
FA of ExCap 0.14 7.22∗∗ 0.22
Group 0.17 0.03 4.45∗ 78.57 0.23
#p < 0.10, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
is still under debate whether atrophy of NbM volume occurs
in VCI. In the present study, using the recently developed
stereotaxic cytoarchitectonic maps of NbM based on combined
magnetic resonance imaging and histology of postmortem brains
(Teipel et al., 2005; Grothe et al., 2010), we revealed that no
significant NbM atrophy was observed in VCIND. Furthermore,
the consistency between our findings in VCIND patients, which
represent an early stage of VCI, and previous findings in
postmortem studies, which represent the advanced stage of VCI,
suggests that there is no significant NbM atrophy across the entire
disease spectrum.
The specific and accurate measurements of WM lesions
along the cholinergic pathway have remained undefined. So
far most of the WM lesions in the cholinergic system were
observed in postmortem brain studies (Tomimoto et al., 2005;
Jung et al., 2012) or measured by visual counting of WM
hyperintensities within cholinergic pathways (Behl et al., 2007;
Kim et al., 2013). Such methods could not specifically measure
the cholinergic pathway lesions. Therefore, the present study
applied probabilistic tractography analysis to track the potential
WM pathway mapping to the cholinergic pathways. The two
major fiber tracks that map to the cholinergic pathway were
both reconstructed in vivo. The tractography revealed fiber
projections from the NbM to the cingulum via the genu
portion of the corpus callosum in the medial pathway and
to the ExCap and Claus divisions in the lateral pathway,
following the cholinergic pathways previously identified by
immunohistochemical procedures (Selden et al., 1998). Within
the pathways, we found an impaired WM microstructure in
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the VCIND patients compared with controls. The FA and
diffusive component alteration patterns in the patients suggested
a loss/disruption of both axons (Teipel et al., 2014) and myelin
(Madden et al., 2012) as well as increased brain water content
(Sen and Basser, 2005) in VCIND, an early stage of VCI. It also
suggests that diffusive alteration may be an early marker for VCI,
as noted in AD (Gold et al., 2014).
Using CHIPS measurement, the associations of ischemic
damage in cholinergic pathways with global cognitive
impairment (Kim et al., 2012, 2013) and executive dysfunction
(Swartz et al., 2003; Behl et al., 2007) have been reported.
However, the underlying mechanism was still undetermined.
Here, based on the in vivo reconstructed pathways carrying
cholinergic input, partial correlation analyses revealed that FA
was correlated with general cognitive assessments in CDR-SB,
MoCA, MMSE, and with single cognitive domain assessments
in memory, language and executive function. Furthermore,
although FA-cognition associations were identified, it is unclear
whether these associations were due to contribution from a third
variable or whether the group-related cognitive differences were
due to the group FA differences. Mediation analysis revealed
that FA decline along the cholinergic pathways could fully
explain the group-related differences in executive functions,
especially the scores measured in the CDT and BDS, and
partly explain group-related variance in global cognition
(MoCA) and memory (AVLT). This suggests that WML in
cholinergic pathways contribute to cognitive dysfunction in
VCIND.
Our results provided better understanding of the
characteristics of cognitive impairment in VCI patients.
Executive dysfunction is the characteristic impairment in
subcortical VCI (Jokinen et al., 2006), which, as indicated
by our results, could be fully explained by damage in WM
microstructure. As noted by Mesulam (2012), cholinergic
pathways do not encode the content of experiences but may
instead influence their inhibitory processing in executive
functions. Moreover, as shown in Figure 2, the lateral pathway
projects fibers into anterior corona radiata, an important pathway
connecting the frontal and basal ganglia executive loop. Such a
distribution pattern of the WM fiber track is also consistent with
the fact that the damage in WM microstructure fully mediates
executive dysfunction. For memory and global cognition, the
FA in ExCap division significantly explained the group-related
variation in MoCA, and the FA in the ExCap and Claus
significantly explained the group-related variation in AVLT. The
role of the lateral pathway lesion in memory was consistent
with its fiber projection tractography, which projects into the
temporal lobe and merges with medial temporal memory-related
regions. The lateral pathway also has widespread projections to
the frontal, temporal and occipital lobes, and therefore lesions in
the lateral pathway would affect global cognition.
A potential limitation in the interpretation of our data is
the cross-sectional nature of the current study. Longitudinal
observations from early stage VCIND to dementia would help
us to better understand the dynamic changes and temporal role
of cholinergic lesions in the pathogenesis of VCI. Moreover, a
previous study revealed that the ascending cholinergic axons
of the nucleus basalis are mostly unmyelinated (Wainer and
Mesulam, 1990). It is hard to distinguish unmyelinated from
myelinated axons in DTI. Thus, in future studies, a combination
of DTI with MRS, a technique to investigate neurochemical
alterations, may help to uncover the unmyelinated fiber axons
in the cholinergic pathway. Thirdly, as demonstrated by
post-mortem studies, the co-occurrence of VCI and other
neurodegenerative disorders in the elderly is very frequent
(McAleese et al., 2016). We could not exclude the possibility
that the VCIND patients included in our study might also
suffer from other confounding preclinical cognitive disorders.
A further cross-validation study with properly controlled
diagnostic biomarkers for AD, Lewy body diseases etc. would be
needed. Finally, it should be noted that the preserved volume
could not exclude the possibility of neuron atrophy in NbM.
In summary, using probabilistic tractography analysis, our
study tracked the two major pathways carrying cholinergic
input. Targeting the early stage of VCI, we further revealed
that the WM decline along the cholinergic pathways, but not
the NbM, is significantly impaired in VCIND. The disrupted
WM pathways could fully explain the executive dysfunction and
partly mediate the memory and global cognition impairments
in VICND. Our results provided better understanding of the
cognitive profiles in VCI patients and suggested that MRI-
based in vivo tracking of cholinergic pathways together with
NbM measurement may become a valuable in vivo marker for
evaluating the cholinergic system in VCI and other cognitive
disorders, including AD. A further cross-validation study
with properly controlled diagnostic biomarkers for possible
confounding neurodegenerative disorders would be needed.
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